217 related articles for article (PubMed ID: 31414226)
1. Peripheral blood mononuclear cell proteome profile in Behçet's syndrome.
Kirectepe Aydin A; Özgüler Y; Uçar D; Kasap M; Akpınar G; Seyahi E; Tahir Turanli E
Rheumatol Int; 2020 Jan; 40(1):65-74. PubMed ID: 31414226
[TBL] [Abstract][Full Text] [Related]
2. Protein profiles of peripheral blood mononuclear cells as a candidate biomarker for Behçet's disease.
Yoshioka T; Kurokawa MS; Sato T; Nagai K; Iizuka N; Arito M; Takakuwa Y; Nakano H; Ooka S; Suematsu N; Okamoto K; Yudoh K; Nakamura H; Suzuki N; Ozaki S; Kato T
Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S9-19. PubMed ID: 24237878
[TBL] [Abstract][Full Text] [Related]
3. The clinical potential of blood-proteomics in multiple sclerosis.
De Masi R; Pasca S; Scarpello R; Idolo A; De Donno A
BMC Neurol; 2013 May; 13():45. PubMed ID: 23692923
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Behçet's syndrome.
Bettiol A; Becatti M; Silvestri E; Argento FR; Fini E; Mannucci A; Galora S; Mattioli I; Urban ML; Malandrino D; Palermo A; Taddei N; Emmi G; Prisco D; Fiorillo C
Clin Exp Immunol; 2021 Dec; 206(3):410-421. PubMed ID: 34562315
[TBL] [Abstract][Full Text] [Related]
5. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease.
Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A
J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684
[TBL] [Abstract][Full Text] [Related]
6. [Screen and identify of differential proteins expressed in the placenta of Down's syndrome].
Yan LY; Sun CJ; Wang X; Chen Y; Zhang WY
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):161-6. PubMed ID: 21575446
[TBL] [Abstract][Full Text] [Related]
7. New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.
Santarsiero A; Leccese P; Convertini P; Padula A; Abriola P; D'Angelo S; Bisaccia F; Infantino V
Mediators Inflamm; 2018; 2018():1419352. PubMed ID: 30050389
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome.
Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH
Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202
[TBL] [Abstract][Full Text] [Related]
9. The analysis of human conjunctival epithelium proteome in ocular surface diseases using impression cytology and 2D-DIGE.
Soria J; Acera A; Durán JA; Boto-de-Los-Bueis A; Del-Hierro-Zarzuelo A; González N; Reigada R; Suárez T
Exp Eye Res; 2018 Feb; 167():31-43. PubMed ID: 28336260
[TBL] [Abstract][Full Text] [Related]
10. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
[TBL] [Abstract][Full Text] [Related]
11. A unique circulating miRNA profile highlights thrombo-inflammation in Behçet's syndrome.
Emmi G; Bagni G; Lastraioli E; Di Patti F; Bettiol A; Fiorillo C; Becatti M; Silvestri E; Urban ML; Emmi L; Prisco D; Arcangeli A
Ann Rheum Dis; 2022 Mar; 81(3):386-397. PubMed ID: 34844932
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Bizhongxiao decoction on proteomics of peripheral blood mononuclear cells in patients with rheumatoid arthritis].
Jiang YQ; Liang QH; Xiong XG
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Nov; 30(11):1160-4. PubMed ID: 21275167
[TBL] [Abstract][Full Text] [Related]
13. Update on the treatment of Behçet's syndrome.
Esatoglu SN; Hatemi G
Intern Emerg Med; 2019 Aug; 14(5):661-675. PubMed ID: 30684097
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline administration changes protein expression profile of coronary artery disease patients.
Shamsara J; Behravan J; Falsoleiman H; Mohammadpour AH; Rendeirs J; Ramezani M
Gene; 2011 Nov; 487(1):107-11. PubMed ID: 21839816
[TBL] [Abstract][Full Text] [Related]
15. Investigation of serum proteome alterations in human glioblastoma multiforme.
Gollapalli K; Ray S; Srivastava R; Renu D; Singh P; Dhali S; Bajpai Dikshit J; Srikanth R; Moiyadi A; Srivastava S
Proteomics; 2012 Aug; 12(14):2378-90. PubMed ID: 22684992
[TBL] [Abstract][Full Text] [Related]
16. Epigenome-wide scan identifies a treatment-responsive pattern of altered DNA methylation among cytoskeletal remodeling genes in monocytes and CD4+ T cells from patients with Behçet's disease.
Hughes T; Ture-Ozdemir F; Alibaz-Oner F; Coit P; Direskeneli H; Sawalha AH
Arthritis Rheumatol; 2014 Jun; 66(6):1648-58. PubMed ID: 24574333
[TBL] [Abstract][Full Text] [Related]
17. Application of 2-dimensional difference gel electrophoresis (2D-DIGE) to the study of thrombin-activated human platelet secretome.
Della Corte A; Maugeri N; Pampuch A; Cerletti C; de Gaetano G; Rotilio D
Platelets; 2008 Feb; 19(1):43-50. PubMed ID: 18231937
[TBL] [Abstract][Full Text] [Related]
18. Behçet's syndrome: a critical digest of the 2014-2015 literature.
Hatemi G; Seyahi E; Fresko I; Talarico R; Hamuryudan V
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S3-14. PubMed ID: 26487500
[TBL] [Abstract][Full Text] [Related]
19. Behcet's Syndrome.
Dalvi SR; Yildirim R; Yazici Y
Drugs; 2012 Dec; 72(17):2223-41. PubMed ID: 23153327
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial.
Hamuryudan V; Hatemi G; Tascilar K; Sut N; Ozyazgan Y; Seyahi E; Mat C; Yurdakul S; Yazici H
Rheumatology (Oxford); 2010 Jan; 49(1):173-7. PubMed ID: 19995858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
